Cyclophosphamide, Fludarabine, Mitoxantrone, and Rituximab
About
Membership operator: AND
Therapies: 4
Therapies
Cyclophosphamide (tx:ncit:C405)
Fludarabine (tx:ncit:C1094)
Mitoxantrone (tx:ncit:C62050)
Rituximab (tx:ncit:C1702)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | CD20 + | Non-Hodgkin Lymphoma | Cyclophosphamide, Fludarabine, Mitoxantrone, Rituximab |